228 related articles for article (PubMed ID: 18209591)
21. [Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration].
Li T; Lin R; Du S; Qu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):19-21. PubMed ID: 9949235
[TBL] [Abstract][Full Text] [Related]
22. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
23. [The role of zinc in the initial treatment of Wilson's disease in children].
Cacić M; Percl M; Jadresin O; Kolacek S
Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between bone mineral content and growth disorders in children with juvenile idiopathic arthritis].
Górska A; Urban M; Konstantynowicz J; Bartnicka M; Chlabicz S; Górski S; Kaczmarski M
Pol Merkur Lekarski; 2008 Mar; 24(141):227-30. PubMed ID: 18634288
[TBL] [Abstract][Full Text] [Related]
25. Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment.
Arnon R; Calderon JF; Schilsky M; Emre S; Shneider BL
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):596-602. PubMed ID: 17460493
[TBL] [Abstract][Full Text] [Related]
26. Serum nitric oxide levels in children with Wilson's disease.
Selimoglu MA; Ertekin V; Turkan Y; Akcay F
Int J Clin Pract; 2007 Sep; 61(9):1530-4. PubMed ID: 17535304
[TBL] [Abstract][Full Text] [Related]
27. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children.
Müller T; Koppikar S; Taylor RM; Carragher F; Schlenck B; Heinz-Erian P; Kronenberg F; Ferenci P; Tanner S; Siebert U; Staudinger R; Mieli-Vergani G; Dhawan A
J Hepatol; 2007 Aug; 47(2):270-6. PubMed ID: 17449133
[TBL] [Abstract][Full Text] [Related]
28. Bone mineral density in children with myelomeningocele.
Apkon SD; Fenton L; Coll JR
Dev Med Child Neurol; 2009 Jan; 51(1):63-7. PubMed ID: 18811711
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density of vegetarian and non-vegetarian adults in Taiwan.
Wang YF; Chiu JS; Chuang MH; Chiu JE; Lin CL
Asia Pac J Clin Nutr; 2008; 17(1):101-6. PubMed ID: 18364334
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral abnormalities in persons with HIV infection: signal or noise?
Singh K; Moyle GJ
AIDS Read; 2006 Aug; 16(8):407-10, 413-8. PubMed ID: 16933375
[TBL] [Abstract][Full Text] [Related]
31. Bone mineral density in Iranian adolescents and young adults with beta-thalassemia major.
Shamshirsaz AA; Bekheirnia MR; Kamgar M; Pakbaz Z; Tabatabaie SM; Bouzari N; Pourzahedgilani N; Azarkeivan A; Hashemi SR; Moosavi F; Alebouyeh M; Vosough P; Kimiagar M; Shamshirsaz AA; Moradi M; Habibzadeh MR; Nobakhthaghighi N; Larijani B
Pediatr Hematol Oncol; 2007; 24(7):469-79. PubMed ID: 17786783
[TBL] [Abstract][Full Text] [Related]
32. Low bone mass due to sickle cell anemia: is it becoming a real issue?
Sadat-Ali M; Al-Elq AH; Sultan O; Al-Turki H; Bukhari R; Al-Mulhim E
West Afr J Med; 2008 Oct; 27(4):218-23. PubMed ID: 19469399
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
Chou IJ; Lin KL; Wang HS; Wang CJ
Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.
Leinweber B; Möller JC; Scherag A; Reuner U; Günther P; Lang CJ; Schmidt HH; Schrader C; Bandmann O; Czlonkowska A; Oertel WH; Hefter H
Mov Disord; 2008 Jan; 23(1):54-62. PubMed ID: 17960799
[TBL] [Abstract][Full Text] [Related]
35. Bone mineral density in male schizophrenia patients: a review.
Meyer JM; Lehman D
Ann Clin Psychiatry; 2006; 18(1):43-8. PubMed ID: 16517452
[TBL] [Abstract][Full Text] [Related]
36. Metal element excretion in 24-h urine in patients with Wilson disease under treatment of D-penicillamine.
Huang L; Yu X; Zhang J; Liu X; Zhang Y; Jiao X; Yu X
Biol Trace Elem Res; 2012 May; 146(2):154-9. PubMed ID: 22076732
[TBL] [Abstract][Full Text] [Related]
37. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
Wadhwa VK; Weston R; Mistry R; Parr NJ
BJU Int; 2009 Sep; 104(6):800-5. PubMed ID: 19338564
[TBL] [Abstract][Full Text] [Related]
38. Results of treatment of Wilson's disease--own observations.
Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
[TBL] [Abstract][Full Text] [Related]
39. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy.
Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M
Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694
[TBL] [Abstract][Full Text] [Related]
40. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
La Vignera S; Vicari E; Tumino S; Ciotta L; Condorelli R; Vicari LO; Calogero AE
Minerva Ginecol; 2008 Dec; 60(6):475-84. PubMed ID: 18981975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
